HCA Healthcare, Inc. (NYSE:HCA) SVP Phillip G. Billington Sells 3,897 Shares

HCA Healthcare, Inc. (NYSE:HCAGet Free Report) SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. This trade represents a 6.89 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

HCA Healthcare Stock Down 2.0 %

Shares of HCA Healthcare stock traded down $7.01 on Friday, hitting $338.50. The company had a trading volume of 320,648 shares, compared to its average volume of 1,179,386. HCA Healthcare, Inc. has a twelve month low of $238.82 and a twelve month high of $417.14. The firm has a market capitalization of $85.74 billion, a P/E ratio of 15.15, a P/E/G ratio of 1.34 and a beta of 1.68. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The stock has a 50-day moving average of $386.00 and a 200-day moving average of $357.03.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.78%. HCA Healthcare’s dividend payout ratio is 11.85%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on HCA shares. Truist Financial raised their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. UBS Group lifted their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research note on Wednesday, August 14th. KeyCorp reduced their target price on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research report on Monday, October 28th. Morgan Stanley began coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target for the company. Finally, Leerink Partners raised their price objective on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Five research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $385.00.

Get Our Latest Stock Report on HCA Healthcare

Institutional Investors Weigh In On HCA Healthcare

Several hedge funds have recently added to or reduced their stakes in HCA. Bangor Savings Bank boosted its position in shares of HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after acquiring an additional 45 shares during the period. MFA Wealth Advisors LLC bought a new position in shares of HCA Healthcare during the second quarter worth approximately $27,000. Unique Wealth Strategies LLC bought a new position in shares of HCA Healthcare in the 2nd quarter valued at $28,000. GPS Wealth Strategies Group LLC grew its position in HCA Healthcare by 284.0% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after acquiring an additional 71 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. bought a new stake in HCA Healthcare in the second quarter valued at $33,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

About HCA Healthcare

(Get Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Further Reading

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.